National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2013-02-11
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 03:15:32

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50419-320-01	ML - Milliliter	50419-320	90ecee66-7976-4798-a28b-4810e25959aa	1	2013-02-11

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
50419-320	50419-320-01

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022090-001	EOVIST	GADOXETATE DISODIUM	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2008-07-03
N022090-002	EOVIST	GADOXETATE DISODIUM	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS		RLD	2013-02-04

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022090-001	EOVIST	1.8143GM/10ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2008-07-03	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N022090-002	EOVIST	2.72145GM/15ML (181.43MG/ML)	SOLUTION / INTRAVENOUS	RLD	2013-02-04	`4b0b4de00fa7…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Submission date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022090-001	6039931	2021-11-13	U-1239	2012-05-03	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022090-002	6039931	2021-11-13	U-1239	2018-06-05	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.